Full text is available at the source.
Abstract
A dual-amplification strategy for detecting circulating tumor DNA (ctDNA) achieves a detection limit of 860 aM.
- The electrochemical biosensor integrates CRISPR/Cas12a for precise target recognition and a nanozyme for signal amplification.
- Target ctDNA activates Cas12a, leading to the cleavage of a reporter DNA strand.
- This cleavage releases the nanozyme, resulting in a measurable decrease in the TMB oxidation current.
- The sensor operates effectively within a linear detection range from 1 fM to 1 nM.
Simplified